OtherClinical Investigations
Simplified Quantification of Pittsburgh Compound B Amyloid Imaging PET Studies: A Comparative Analysis
Brian J. Lopresti, William E. Klunk, Chester A. Mathis, Jessica A. Hoge, Scott K. Ziolko, Xueling Lu, Carolyn C. Meltzer, Kurt Schimmel, Nicholas D. Tsopelas, Steven T. DeKosky and Julie C. Price
Journal of Nuclear Medicine December 2005, 46 (12) 1959-1972;
Brian J. Lopresti
William E. Klunk
Chester A. Mathis
Jessica A. Hoge
Scott K. Ziolko
Xueling Lu
Carolyn C. Meltzer
Kurt Schimmel
Nicholas D. Tsopelas
Steven T. DeKosky
Article Information
vol. 46 no. 12 1959-1972
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online December 5, 2005.
Copyright & Usage
THE JOURNAL OF NUCLEAR MEDICINE
Author Information
Statistics from Altmetric.com
Cited By...
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
Article usage
In this issue
Journal of Nuclear Medicine
Vol. 46, Issue 12
December 1, 2005
Simplified Quantification of Pittsburgh Compound B Amyloid Imaging PET Studies: A Comparative Analysis
Brian J. Lopresti, William E. Klunk, Chester A. Mathis, Jessica A. Hoge, Scott K. Ziolko, Xueling Lu, Carolyn C. Meltzer, Kurt Schimmel, Nicholas D. Tsopelas, Steven T. DeKosky, Julie C. Price
Journal of Nuclear Medicine Dec 2005, 46 (12) 1959-1972;
Simplified Quantification of Pittsburgh Compound B Amyloid Imaging PET Studies: A Comparative Analysis
Brian J. Lopresti, William E. Klunk, Chester A. Mathis, Jessica A. Hoge, Scott K. Ziolko, Xueling Lu, Carolyn C. Meltzer, Kurt Schimmel, Nicholas D. Tsopelas, Steven T. DeKosky, Julie C. Price
Journal of Nuclear Medicine Dec 2005, 46 (12) 1959-1972;
Jump to section
Related Articles
Cited By...
- Quantitative Brain Amyloid PET
- Longitudinal Association of Mid-Life Ten Year Cardiovascular Disease Risk Score with Brain Biomarkers of Alzheimers Disease, Neurodegeneration and White Matter Hyper Intensities in Cognitively Unimpaired Older Adults: Heart SCORE Brain Study
- The RSNA QIBA Profile for Amyloid PET as an Imaging Biomarker for Cerebral Amyloid Quantification
- CSF sphingomyelins in Alzheimers disease, neurodegeneration, and neuroinflammation
- Impact of 40 Hz Transcranial Alternating Current Stimulation on Cerebral Tau Burden in Patients with Alzheimers Disease: A Case Series
- MRI-Visible Perivascular Spaces in the Centrum Semiovale Are Associated with Brain Amyloid Deposition in Patients with Alzheimer Disease-Related Cognitive Impairment
- Predicting resistance to amyloid-beta deposition and cognitive resilience in the oldest-old
- Proper names from story recall are associated with beta-amyloid in cognitively unimpaired adults at risk for Alzheimers disease
- Total A{beta}42/A{beta}40 ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis
- Magia: Robust automated image processing and kinetic modeling toolbox for PET neuroinformatics
- Plasma and CSF neurofilament light: Relation to longitudinal neuroimaging and cognitive measures
- Brain Amyloid-{beta} Deposition and Blood Biomarkers in Patients with Clinically Diagnosed Alzheimers Disease
- Generation of Structural MR Images from Amyloid PET: Application to MR-Less Quantification
- Midlife insulin resistance, APOE genotype, and late-life brain amyloid accumulation
- Optimal Reference Region to Measure Longitudinal Amyloid-{beta} Change with 18F-Florbetaben PET
- Standardized Expression of 18F-NAV4694 and 11C-PiB {beta}-Amyloid PET Results with the Centiloid Scale
- FDG-PET and Neuropsychiatric Symptoms among Cognitively Normal Elderly Persons: The Mayo Clinic Study of Aging
- In Vivo Tau, Amyloid, and Gray Matter Profiles in the Aging Brain
- Visualization and Quantification of 3-Dimensional Stereotactic Surface Projections for 18F-Flutemetamol PET Using Variable Depth
- Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment
- Performance of 11C-Pittsburgh Compound B PET Binding Potential Images in the Detection of Amyloid Deposits on Equivocal Static Images
- A Semiautomated Method for Quantification of F 18 Florbetapir PET Images
- Relative 11C-PiB Delivery as a Proxy of Relative CBF: Quantitative Evaluation Using Single-Session 15O-Water and 11C-PiB PET
- Establishing Amyloid PET Imaging Biomarkers: Ongoing Efforts
- Voxelwise Relationships Between Distribution Volume Ratio and Cerebral Blood Flow: Implications for Analysis of {beta}-Amyloid Images
- Measurement of Longitudinal {beta}-Amyloid Change with 18F-Florbetapir PET and Standardized Uptake Value Ratios
- Blood Protein Markers of Neocortical Amyloid-{beta} Burden: A Candidate Study Using SOMAscan Technology
- Automated Quantification of 18F-Flutemetamol PET Activity for Categorizing Scans as Negative or Positive for Brain Amyloid: Concordance with Visual Image Reads
- Amyloid Burden, Neuroinflammation, and Links to Cognitive Decline After Ischemic Stroke
- Cerebral perfusion alterations and cerebral amyloid in autosomal dominant Alzheimer disease
- Apathy correlates with prefrontal amyloid {beta} deposition in Alzheimer's disease
- Longitudinal Amyloid Imaging Using 11C-PiB: Methodologic Considerations
- Implementation and Validation of an Adaptive Template Registration Method for 18F-Flutemetamol Imaging Data
- Brain {beta}-amyloid load approaches a plateau
- Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia
- Cognitive Profile of Amyloid Burden and White Matter Hyperintensities in Cognitively Normal Older Adults
- Indicators of amyloid burden in a population-based study of cognitively normal elderly
- Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease
- Subacute Ischemic Stroke Is Associated With Focal 11C PiB Positron Emission Tomography Retention But Not With Global Neocortical A{beta} Deposition
- Relative Equilibrium Plot Improves Graphical Analysis and Allows Bias Correction of Standardized Uptake Value Ratio in Quantitative 11C-PiB PET Studies
- Performance Characteristics of Amyloid PET with Florbetapir F 18 in Patients with Alzheimer's Disease and Cognitively Normal Subjects
- Clinical Validation of 18F-AZD4694, an Amyloid-{beta}-Specific PET Radioligand
- Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution
- Dual-Biomarker Imaging of Regional Cerebral Amyloid Load and Neuronal Activity in Dementia with PET and 11C-Labeled Pittsburgh Compound B
- Early 11C-PIB Frames and 18F-FDG PET Measures Are Comparable: A Study Validated in a Cohort of AD and FTLD Patients
- In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18)
- Specific estrogen sulfotransferase (SULT1E1) substrates and molecular imaging probe candidates
- Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's
- 11C-PIB binding is increased in patients with cerebral amyloid angiopathy-related hemorrhage
- {beta}-Amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia
- Basal Cerebral Metabolism May Modulate the Cognitive Effects of A{beta} in Mild Cognitive Impairment: An Example of Brain Reserve
- Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls
- Relationships between biomarkers in aging and dementia
- Disruption of Functional Connectivity in Clinically Normal Older Adults Harboring Amyloid Burden
- Characterizing the Appearance and Growth of Amyloid Plaques in APP/PS1 Mice
- Phase 1 Study of the Pittsburgh Compound B Derivative 18F-Flutemetamol in Healthy Volunteers and Patients with Probable Alzheimer Disease
- Comparison of 18F-FDG and PiB PET in Cognitive Impairment
- In vivo mapping of amyloid toxicity in Alzheimer disease
- Fibrillar amyloid-{beta} burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease
- Consideration of Optimal Time Window for Pittsburgh Compound B PET Summed Uptake Measurements
- Cortical Hubs Revealed by Intrinsic Functional Connectivity: Mapping, Assessment of Stability, and Relation to Alzheimer's Disease
- Detection of Alzheimer Pathology In Vivo Using Both 11C-PIB and 18F-FDDNP PET
- Microglial activation and amyloid deposition in mild cognitive impairment: A PET study
- Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography
- Imaging amyloid deposition in Lewy body diseases
- Voxel-Based Analysis of 11C-PIB Scans for Diagnosing Alzheimer's Disease
- Dynamics of the Microglial/Amyloid Interaction Indicate a Role in Plaque Maintenance
- Amyloid Deposition Begins in the Striatum of Presenilin-1 Mutation Carriers from Two Unrelated Pedigrees
- Imaging {beta}-amyloid burden in aging and dementia
- 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration
- 2-(2-[2-Dimethylaminothiazol-5-yl]Ethenyl)-6- (2-[Fluoro]Ethoxy)Benzoxazole: A Novel PET Agent for In Vivo Detection of Dense Amyloid Plaques in Alzheimer's Disease Patients
- Visual Assessment Versus Quantitative Assessment of 11C-PIB PET and 18F-FDG PET for Detection of Alzheimer's Disease
- Amyloid, hypometabolism, and cognition in Alzheimer disease: An [11C]PIB and [18F]FDG PET study
- Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease
- [11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease